Kinshasa, Democratic Republic of the Congo, Aug 15, 2019 / 13:03 pm
Scientists are hopeful after a clinical trial of two experimental drugs in the Democratic Republic of the Congo (DRC) showed promise in treating the deadly Ebola virus.
Regeneron's REGN-EB3 and a monoclonal antibody known as mAb114 were among four experimental drugs being tested in a recent DRC trial, Reuters reported. Both were developed from the antibodies of people who had survived Ebola.
The other two products being tested displayed less success in the clinical trial, and further testing of them has been discontinued.
Ebola is a deadly virus that is primarily spread through contact with bodily fluids. Symptoms include fever, vomiting, diarrhea, muscle pains and occasional bleeding.